Clinical Trial Update: Extension Study of Enteric-coated Mycophenolate Sodium in Combination With Full Dose or Reduced Dose Cyclosporine Microemulsion in Patients With de Novo Kidney Transplants [Phase 3]

View source ↗

Summary

Extension study results for de novo kidney transplant patients treated with enteric-coated mycophenolate sodium in combination with full-dose or reduced-dose cy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)
• cyclosporine microemulsion (cyclosporine)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 3 | Status: COMPLETED